Second phase I/II trial of ICEF 15 for the treatment of faecal incontinence

Trial Profile

Second phase I/II trial of ICEF 15 for the treatment of faecal incontinence

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Dec 2013

At a glance

  • Drugs ICEF 15 (Primary)
  • Indications Faecal incontinence
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Dec 2013 New trial record
    • 17 Dec 2013 Status changed from recruiting to completed. Phase I/II trial data have shown a rapid reduction in the symptoms of faecal incontinence as well as an improvement in the quality of life, according to a Norgine and Innovacell media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top